NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









ProVerum Medical

ProVerum Medical

Private
DublinHealthcare & Life Scienceshttps://www.proverummedical.com/

Last Round

Series B

Aug 25, 2025

Total Funding Raised

$124.7M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

ProVerum Medical is a medical device company that develops minimally invasive technologies for the treatment of benign prostatic hyperplasia.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

benign prostatic hyperplasiaBPHminimally invasive surgeryurology medical deviceprostatic implanturologyoffice-based urologynitinol implantprostatic expanderurological implantsmen's healthminimally invasive urologyurology techTURP alternative

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ProVerum Medical Comps

Public and private peers based on sector, stage, and business model.

ProVerum Medical comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

ProVerum Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BAug 25, 2025
GrantMar 8, 2025
Series AJan 11, 2022
GrantMar 12, 2020
SeedJul 12, 2018

Key People

Founding team and executive leadership

Ríona Ní Ghriallais

Chief Technology Officer

Executive Team

Jesse Litwak

Chief Financial Officer

Executive Team

ProVerum Medical Investors

Notable investors and investment history

ProVerum Medical investors
InvestorRounds
Atlantic Bridge CapitalSeries A, Series B
Lightstone VenturesSeries B, Series A
OrbiMedSeries B
Gilde HealthcareSeries B, Series A
Disruptive Technologies Innovation FundGrant
Irrus InvestmentsSeed
National Treasury Management AgencySeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 26, 2026

    Grew 16% QoQ, from 45 to 52 employees.

  • Apr 25, 2026

    Grew 20% QoQ, from 41 to 49 employees.

ProVerum Medical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

ProVerum Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ProVerum Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersDublin
Employee Range54
Year Founded2016
Last FundingAug 25, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.